Jan Matthes1, Christian Albus. 1. Department of Pharmacology, University of Cologne, Department of Psychosomatics and Psychotherapy, University Hospital of Cologne.
Abstract
BACKGROUND: A common problem among patients with chronic diseases is poor adherence with prescribed medication. Studies have shown that certain interventions can improve adherence and clinical outcomes. METHOD: We selectively searched the PubMed database for publications on the treatment of hypertension that contained the terms "adherence," "drug," "treatment, "outcome," "hypertension," and "randomized controlled trial." RESULTS: The interventions studied were highly varied, ranging from the use of calendar blister packs to complex patient education programs. 62% of the studies that we identified documented an improvement in adherence after an intervention (median Cohen's d = 0.52). In 92% of cases, improved adherence was associated with a significant improvement in clinical end points (median Cohen's d = 0.34). CONCLUSION: The promotion of adherence to prescribed medication is clearly desirable. Studies on the treatment of hypertension have shown that attempts to improve adherence often fail. In most studies, however, improved adherence led to better clinical outcomes. Simplification of drug regimens (e.g., reducing the number of pills taken per day) is the single most effective way to promote adherence. Moreover, the findings of studies on the treatment of hypertension and other diseases suggest that shared decision-making should be the basis of physicianpatient discussions about medication. Suitable medications can also be chosen in order to maximize safety and efficacy even if adherence is incomplete. It would also be desirable for studies on the promotion of adherence to be carried out in Germany, under the specific conditions that prevail in our national health-care system.
BACKGROUND: A common problem among patients with chronic diseases is poor adherence with prescribed medication. Studies have shown that certain interventions can improve adherence and clinical outcomes. METHOD: We selectively searched the PubMed database for publications on the treatment of hypertension that contained the terms "adherence," "drug," "treatment, "outcome," "hypertension," and "randomized controlled trial." RESULTS: The interventions studied were highly varied, ranging from the use of calendar blister packs to complex patient education programs. 62% of the studies that we identified documented an improvement in adherence after an intervention (median Cohen's d = 0.52). In 92% of cases, improved adherence was associated with a significant improvement in clinical end points (median Cohen's d = 0.34). CONCLUSION: The promotion of adherence to prescribed medication is clearly desirable. Studies on the treatment of hypertension have shown that attempts to improve adherence often fail. In most studies, however, improved adherence led to better clinical outcomes. Simplification of drug regimens (e.g., reducing the number of pills taken per day) is the single most effective way to promote adherence. Moreover, the findings of studies on the treatment of hypertension and other diseases suggest that shared decision-making should be the basis of physicianpatient discussions about medication. Suitable medications can also be chosen in order to maximize safety and efficacy even if adherence is incomplete. It would also be desirable for studies on the promotion of adherence to be carried out in Germany, under the specific conditions that prevail in our national health-care system.
Authors: Joyce A Cramer; Anuja Roy; Anita Burrell; Carol J Fairchild; Mahesh J Fuldeore; Daniel A Ollendorf; Peter K Wong Journal: Value Health Date: 2008 Jan-Feb Impact factor: 5.725
Authors: Gbenga Ogedegbe; William Chaplin; Antoinette Schoenthaler; David Statman; David Berger; Tabia Richardson; Erica Phillips; Jacqueline Spencer; John P Allegrante Journal: Am J Hypertens Date: 2008-07-24 Impact factor: 2.689
Authors: Amanda D Hyre; Marie A Krousel-Wood; Paul Muntner; Lumie Kawasaki; Karen B DeSalvo Journal: J Clin Hypertens (Greenwich) Date: 2007-03 Impact factor: 3.738
Authors: Katarina Hauser; Armin Koerfer; Kathrin Kuhr; Christian Albus; Stefan Herzig; Jan Matthes Journal: Dtsch Arztebl Int Date: 2015-10-02 Impact factor: 5.594
Authors: Nesrine Ben Nasr; Anne Rouault; Nicolas Cornillet; Marie Bruandet; Hélène Beaussier; Isabelle Tersen; Yvonnick Bezie; Mathieu Zuber Journal: Int J Clin Pharm Date: 2018-11-26